Considering the effects of the above targets on glioma, a series of small molecule inhibitors targeting the MAT2A–PRMT5 signal axis including a brain penetrating PRMT5-MTA inhibitor and MAT2A inhibitor [26] was recently and separately synthesized by our research group to test their effects when used alone or in combination. Here, PRMT5 is linked to central nervous system cancer.